Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
IBRO Neuroscience Reports|July 1, 2026
Spinal cord transverse section hinders Wallerian degeneration and neoangiogenesis after peripheral nerve transection: Involvement of Schwann cells' miR-134-5pLingli Jiang, Fang Zhang, Fang Qi, et al.
Journal of Nanobiotechnology|June 11, 2026
DNA hydrogel-delivered hypoxic exosomes alleviate radiation-induced skin injury by stabilizing AKTQing Yin, Shihua Deng, Ye Liu, et al.
Oncogene|October 31, 2021
Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancerChune Yu, Dan Luo, Jing Yu, et al.
Nature Communications|April 20, 2026
T-cell mesenchymal transition represents a potential pathogenic mechanism of female cancer-related lymphedemaLiangliang Wang, Junzhe Chen, Miaomiao Wei, et al.
Advances in Wound Care|April 8, 2026
Engineered Mesenchymal Stem Cells with Endogenous Trehalose Expression Activate the NRF2-HMOX1 Pathway to Enhance Antioxidant Stress and Wound Healing CapacityZhen Wang, Xin Liu, Xin Chen, et al.
Stem Cells Translational Medicine|October 15, 2024
eIF6 modulates skin wound healing by upregulating keratin 6BXiaoyan Wang, Guangchao Xu, Fangyingnan Zhang, et al.
Scientific Reports|September 22, 2020
Author Correction: A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblastsMeihua Chen, Rong Xiang, Yuan Wen, et al.
The Journal of Investigative Dermatology|August 6, 2021
The Evolution of Acquired Resistance to BRAFV600E kinase inhibitor Is Sustained by IGF1-Driven Tumor Vascular RemodelingGuangchao Xu, Ya Luo, Wenshuang Wu, et al.
Scientific Reports|September 24, 2015
A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblastsMeihua Chen, Rong Xiang, Yuan Wen, et al.
Scientific Reports|October 21, 2017
Corrigendum: A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblastsMeihua Chen, Rong Xiang, Yuan Wen, et al.
Pageof 4